Election Day is coming — are you registered to vote?
119th Congress
Independent · Nonpartisan · Reader-supported
HOUSEH.R. 3029· 119th Congress

Bill Requires NIST to Develop Standards for Safe Nucleic Acid Synthesis

To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

Sponsor
Andrea Salinas (D-OR)
Introduced
Apr 28, 2025
Last Action
Jul 21, 2026

Recorded legislative actions. Future votes are not implied.

✓
In Committee
Apr 28, 2025
✓
Passed Committee
Apr 29, 2025
✓
Passed Committee
Jul 16, 2026
✓
Passed House
Jul 20, 2026
✓
Received in Senate
Jul 21, 2026

AI-assisted analysis based on the official CRS summary. Source version: Jul 20, 2026. Analysis updated: Sep 15, 2026.

01 — The Text

What.

  • The bill requires the National Institute of Standards and Technology (NIST) to support development of best practices and technical standards for nucleic acid synthesis (the process of designing and creating custom DNA and RNA).
  • NIST must conduct measurement research addressing nucleic acid synthesis screening, operational security, and conformity assessment to support biosecurity.
  • NIST must convene stakeholders to develop and periodically update consensus priorities and best practices for synthetic nucleic acid screening mechanisms.
  • NIST must submit a summary of stakeholder group findings to Congress within a specified period.
  • NIST must advance risk management best practices and technical standards for engineering biology and biomanufacturing, including risks related to artificial intelligence use.
02 — The Stakes

So what?

  • The bill establishes a formal requirement for NIST to address biosecurity risks from nucleic acid synthesis, which can be misused to create dangerous biological agents.
  • Stakeholder engagement is mandated to ensure screening standards reflect input from relevant parties.
  • Congressional reporting requirement creates accountability for NIST's progress on these standards.
  • Effects on actual synthesis screening adoption, enforcement mechanisms, or timeline for standard implementation are not established in the official summary.
03 — The Path

Now what?

  • House passed the bill on July 20, 2026 by voice vote under suspension of rules.
  • Bill was referred to Senate Committee on Commerce, Science, and Transportation on July 21, 2026.
  • A 2023 executive order previously directed NIST to develop similar specifications; this bill formalizes that work in statute.
  • No scheduled Senate vote or further action date is documented.
Legislative History

Actions.

  • Jul 21, 2026 — Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
  • Jul 20, 2026 — Motion to reconsider laid on the table Agreed to without objection.
  • Jul 20, 2026 — On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
  • Jul 20, 2026 — Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
  • Jul 20, 2026 — DEBATE - The House proceeded with forty minutes of debate on H.R. 3029.
  • Jul 20, 2026 — Considered under suspension of the rules. (consideration: CR H4666-4667)
  • Jul 20, 2026 — Mr. Babin moved to suspend the rules and pass the bill, as amended.
  • Jul 16, 2026 — Placed on the Union Calendar, Calendar No. 654.